Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It focuses on Depression.
Multiple locations, including Baltimore
This study is completed in the United States. It is testing psilocybin for depression.
Multiple locations, including San FranciscoThis study is active but not recruiting in the United States. It is testing psilocybin for PTSD.
In Baltimore
This study is completed in China. It is testing repetitive Transcranial Magnetic Stimulation for Bipolarity.
In GuangzhouThis study is completed in the United States. It is testing safety and Tolerability for schizophrenia.
Multiple locations, including Garden Grove
This study is enrolling by invitation in Norway. It is testing School Absenteeism and Student Well-being for Depression.
In OsloThis study is completed in the United States, in Brazil, in Bulgaria, .... It is testing seltorexant for depression.
Multiple locations, including AnaheimThis study is completed in the United States. It is testing SEP-380135 for depression.
In Los AlamitosThis study is completed in the United States. It focuses on PTSD.
In BostonThis study was withdrawn in the United States. It is testing SPD465 for ADHD.
In TampaThis study is completed in the United States. It is testing spoken Language for Bipolarity.
In RochesterThis study is completed in the United States, in the United Kingdom, in Belgium, .... It is testing TAK-503 for ADHD.
Multiple locations, including DothanHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.